Publication:


abstract


Related Articles
The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings.
Ann Intern Med. 2012
The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings.
Rein DB, Smith BD, Wittenborn JS, Lesesne SB, Wagner LD, Roblin DW, Patel N, Ward JW, Weinbaum CM. Ann Intern Med. 2012 Feb 21; 156(4):263-70. Epub 2011 Nov 4.
Review Clinical practice. Chronic hepatitis C infection.
N Engl J Med. 2011
Review Clinical practice. Chronic hepatitis C infection.
Rosen HR. N Engl J Med. 2011 Jun 23; 364(25):2429-38.
New protease inhibitors for the treatment of chronic hepatitis C: a cost-effectiveness analysis.
Ann Intern Med. 2012
New protease inhibitors for the treatment of chronic hepatitis C: a cost-effectiveness analysis.
Liu S, Cipriano LE, Holodniy M, Owens DK, Goldhaber-Fiebert JD. Ann Intern Med. 2012 Feb 21; 156(4):279-90.
An update on treatment of hepatitis C virus genotype 1 infection and viral load assessments.
Hepatology. 2012
An update on treatment of hepatitis C virus genotype 1 infection and viral load assessments.
Cobb B, Vilchez RA. Hepatology. 2012 Mar; 55(3):979-80; author reply 980-1.
Review Hepatitis C in pregnancy.
Curr Gastroenterol Rep. 2005
Review Hepatitis C in pregnancy.
Su GL. Curr Gastroenterol Rep. 2005 Feb; 7(1):45-9.